1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Polypoidal Choroidal Vasculopathy: new trials by email Literature Review of Polypoidal Choroidal Vasculopathy trials Research Report on Polypoidal Choroidal Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) iSONEP (sonepcizumab/LT1009) - Pigment Epithelial Detachment | Phase 1 | Terminated | Lpath, Inc. | 12 | 2011-03-01 | 2013-04-23 |
Choroid Diseases (1) · Choroidal Neovascularization (1) · Eye Diseases (1) · Metaplasia (1) · Neovascularization, Pathologic (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Retinal Diseases (1) · Uveal Diseases (1)
sonepcizumab (1)
Lpath, Inc. (1)
United States (1)